home / stock / exas / exas news


EXAS News and Press, Exact Sciences Corporation From 05/08/24

Stock Information

Company Name: Exact Sciences Corporation
Stock Symbol: EXAS
Market: NASDAQ
Website: exactsciences.com

Menu

EXAS EXAS Quote EXAS Short EXAS News EXAS Articles EXAS Message Board
Get EXAS Alerts

News, Short Squeeze, Breakout and More Instantly...

EXAS - Exact Sciences down 17% on quarterly bottom line miss, maintaining 2024 guidance

2024-05-08 17:28:07 ET More on Exact Sciences Exact Sciences: Cancer Battle Continues, Shares Likely To Plateau Exact Sciences Corporation (EXAS) Q4 2023 Earnings Call Transcript Exact Sciences Corporation 2023 Q4 - Results - Earnings Call Presentation Exact ...

EXAS - Exact Sciences GAAP EPS of -$0.60 misses by $0.11, revenue of $637.52M beats by $10.71M

2024-05-08 16:08:34 ET More on Exact Sciences Exact Sciences: Cancer Battle Continues, Shares Likely To Plateau Exact Sciences Corporation (EXAS) Q4 2023 Earnings Call Transcript Exact Sciences Corporation 2023 Q4 - Results - Earnings Call Presentation Exact ...

EXAS - Exact Sciences Announces First-Quarter 2024 Results

First quarter highlights Delivered total first quarter revenue of $638 million, an increase of 6% on a reported and core revenue basis, including Screening revenue of $475 million and Precision Oncology revenue of $163 million Published Cologuard Plus™ test results from pivotal...

EXAS - Expected US Company Earnings on Wednesday, May 8th, 2024

Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...

EXAS - Exact Sciences Demonstrates Continued Scientific Advancement in Colorectal Cancer Screening with Multiple Data Presentations at DDW® 2024

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, announced today the company will present six abstracts on strategies and advancements for improving colorectal cancer screening rates and outcomes during Digestive Disease Week ® (DDW) 2024,...

EXAS - LabCorp partner Geneoscopy wins FDA approval of colorectal cancer test ColoSense

2024-05-06 16:35:21 ET More on LabCorp Laboratory Corporation of America Holdings (LH) Q1 2024 Earnings Call Transcript Laboratory Corporation: A Healthier Diagnosis, As Pandemic Headwinds Disappear Laboratory Corporation of America Holdings (LH) Q4 2023 Earnings Cal...

EXAS - RDFN, EXAS, PEG, REVG, ALT showing five-day upward surge

2024-05-06 10:45:03 ET Redfin Corp (RDFN) RDFN is trading UP for the last 5 days, and it at trading at $6.41 with volume of 1,169,515 and a one day change of $0.21 (3.39%). Redfin Corp has a 52-week low of 4.26 and a 52-week high of $17.68. The business's 50-day moving average price...

EXAS - Earnings week ahead: Disney, Palantir, Shopify, Uber, Plug Power and more

2024-05-05 08:00:00 ET As Wall Street embarks on the first full week of May, a diverse group of companies is set to report financial results. Notable names include The Walt Disney Company ( NYSE: DIS ), Palantir Technologies ( NYSE: PLTR ), Realty Income ( NYSE: ...

EXAS - Exact Sciences to Participate in May Investor Conference

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate by webcast. BofA Securities Health Care Conference, Las Vegas Firesid...

EXAS - Where are the Opportunities in (EXAS)

2024-05-01 02:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Previous 10 Next 10